Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections

Texto completo
Autor(es):
Kischkel, Brenda [1, 2] ; Rossi, Suelen A. [1, 2] ; Santos, Jr., Samuel R. [1, 2] ; Nosanchuk, Joshua D. [3, 4] ; Travassos, Luiz R. [5] ; Taborda, Carlos P. [1, 2]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo - Brazil
[2] Univ Sao Paulo, Med Sch, Inst Trop Med Sao Paulo LIM53, Lab Med Mycol, Sao Paulo - Brazil
[3] Albert Einstein Coll Med, Div Infect Dis Microbiol & Immunol, Dept Med, Bronx, NY 10467 - USA
[4] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 - USA
[5] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo - Brazil
Número total de Afiliações: 5
Tipo de documento: Artigo de Revisão
Fonte: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY; v. 10, SEP 3 2020.
Citações Web of Science: 1
Resumo

Treatment modalities for systemic mycoses are still limited. Currently, the main antifungal therapeutics include polyenes, azoles, and echinocandins. However, even in the setting of appropriate administration of antifungals, mortality rates remain unacceptably high. Moreover, antifungal therapy is expensive, treatment periods can range from weeks to years, and toxicity is also a serious concern. In recent years, the increased number of immunocompromised individuals has contributed to the high global incidence of systemic fungal infections. Given the high morbidity and mortality rates, the complexity of treatment strategies, drug toxicity, and the worldwide burden of disease, there is a need for new and efficient therapeutic means to combat invasive mycoses. One promising avenue that is actively being pursued is nanotechnology, to develop new antifungal therapies and efficient vaccines, since it allows for a targeted delivery of drugs and antigens, which can reduce toxicity and treatment costs. The goal of this review is to discuss studies using nanoparticles to develop new therapeutic options, including vaccination methods, to combat systemic mycoses caused byCandidasp.,Cryptococcussp.,Paracoccidioidessp.,Histoplasmasp.,Coccidio idessp., andAspergillussp., in addition to providing important information on the use of different types of nanoparticles, nanocarriers and their corresponding mechanisms of action. (AU)

Processo FAPESP: 16/08730-6 - Patogenicidade fúngica: efeito do tabagismo, resposta imune e a modulação vacinal na paracoccidioidomicose e na histoplasmose
Beneficiário:Carlos Pelleschi Taborda
Linha de fomento: Auxílio à Pesquisa - Temático
Processo FAPESP: 18/26402-1 - Prospecção de novos epítopos com potencial vacinal no controle da infecção experimental por Histoplasma capsulatum
Beneficiário:Brenda Kischkel
Linha de fomento: Bolsas no Brasil - Doutorado Direto